Current and emerging treatment options for endometriosisSimone Ferrero, Fabio Barra, Giulio Evangelisti|Expert Opinion on Pharmacotherapy|2018Cited by 148
Current Medical Therapy for Adenomyosis: From Bench to BedsideAndrea Etrusco, Antonio Simone Laganà, Fabio Barra et al.|Drugs|2023Cited by 121
Investigational PI3K/AKT/mTOR inhibitors in development for endometrial cancerFabio Barra, Simone Ferrero, Giulio Evangelisti et al.|Expert Opinion on Investigational Drugs|2018Cited by 102
Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomasSusan Dababou, Fabio Barra, Simone Garzon et al.|Expert Opinion on Investigational Drugs|2021Cited by 62
Advances in paclitaxel combinations for treating cervical cancerLuigi Della Corte, Giuseppe Bifulco, Fabio Barra et al.|Expert Opinion on Pharmacotherapy|2020Cited by 60